OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
1-Year Est. Return 7.48%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
-7.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$46.9M
AUM Growth
-$11.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
64
New
Increased
Reduced
Closed

Top Buys

1
+$595K
2
+$297K
3
+$282K
4
ALKS icon
Alkermes
ALKS
+$253K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$64.5K

Top Sells

1
+$868K
2
+$813K
3
+$743K
4
INSM icon
Insmed
INSM
+$690K
5
PCRX icon
Pacira BioSciences
PCRX
+$489K

Sector Composition

1 Healthcare 64.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALKS icon
51
Alkermes
ALKS
$5.74B
$227K 0.48%
+11,632
RARE icon
52
Ultragenyx Pharmaceutical
RARE
$2.44B
$217K 0.46%
5,064
KYNB
53
Kyntra Bio
KYNB
$29.6M
$212K 0.45%
230
+35
SCTL
54
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$126K 0.27%
12,659
AGIO icon
55
Agios Pharmaceuticals
AGIO
$2.06B
– –
-4,806
ANAB icon
56
AnaptysBio
ANAB
$1.94B
– –
-6,116
BLUE
57
DELISTED
bluebird bio
BLUE
– –
-451
FOLD icon
58
Amicus Therapeutics
FOLD
$4.54B
– –
-36,731
INSM icon
59
Insmed
INSM
$31.2B
– –
-26,936
MDGL icon
60
Madrigal Pharmaceuticals
MDGL
$12.2B
– –
-3,570
PCRX icon
61
Pacira BioSciences
PCRX
$1B
– –
-11,250
SRPT icon
62
Sarepta Therapeutics
SRPT
$2.26B
– –
-5,353
VKTX icon
63
Viking Therapeutics
VKTX
$4.08B
– –
-48,485
IMMU
64
DELISTED
Immunomedics Inc
IMMU
– –
-62,575
1 2
3